|
|
|
NGF
|
|
48
disease terms (MeSH) has been reported with NGF gene.
|
[Click  to re-sort the table]
|
|
|
|
Meta-analysis Publications
|
Alzheimer Disease
|
4
|
0
|
|
Anxiety Disorders
|
4
|
0
|
|
Bronchiolitis, Viral
|
3
|
0
|
|
Eating Disorders
|
3
|
0
|
|
Respiratory Syncytial Virus Infections
|
3
|
0
|
|
Disease Models, Animal
|
2
|
0
|
|
Cognitive Therapy
|
2
|
0
|
|
Asthma
|
2
|
0
|
|
Attention Deficit Disorder with Hyperactivity
|
2
|
0
|
|
Heroin Dependence
|
2
|
0
|
|
Mental Disorders
|
2
|
0
|
|
Mood Disorders
|
2
|
0
|
|
Multiple Sclerosis
|
2
|
0
|
|
Neurogenic Inflammation
|
1
|
0
|
|
Neuropsychological Tests
|
1
|
0
|
|
Opioid-Related Disorders
|
1
|
1
|
|
Osteoarthritis, Knee
|
1
|
0
|
|
Pain
|
1
|
0
|
|
Personality Assessment
|
1
|
0
|
|
Personality Inventory
|
1
|
0
|
|
Psychiatric Status Rating Scales
|
1
|
0
|
|
Psychometrics
|
1
|
0
|
|
Hypersensitivity, Immediate
|
1
|
0
|
|
Infant, Premature, Diseases
|
1
|
0
|
|
Inhibition (Psychology)
|
1
|
0
|
|
Kidney Failure, Chronic
|
1
|
0
|
|
Glomerulonephritis, IGA
|
1
|
0
|
|
Hepatitis, Viral, Human
|
1
|
0
|
|
Hereditary Sensory and Autonomic Neuropathies
|
1
|
0
|
|
Autistic Disorder
|
1
|
0
|
|
Bipolar Disorder
|
1
|
0
|
|
Brain Ischemia
|
1
|
0
|
|
Asperger Syndrome
|
1
|
0
|
|
Amnesia
|
1
|
0
|
|
Cues
|
1
|
0
|
|
Dermatitis, Atopic
|
1
|
0
|
|
Dysmenorrhea
|
1
|
0
|
|
Executive Function
|
1
|
0
|
|
Schizophrenia
|
1
|
0
|
|
Social Perception
|
1
|
0
|
|
Stress, Psychological
|
1
|
0
|
|
Stroke
|
1
|
0
|
|
Substance-Related Disorders
|
1
|
0
|
|
Tobacco Use Disorder
|
1
|
0
|
|
Trauma, Nervous System
|
1
|
0
|
|
Trigeminal Neuralgia
|
1
|
0
|
|
Vulvodynia
|
1
|
0
|
|
Alcoholism
|
1
|
0
|
|
Note: The number of publications displayed in this table will differ from the number displayed in the HuGE Literature Finder as the number
in Genopedia reflects only the indexed disease term without children terms, but the number in the HuGE Literature Finder
reflects all text searches of the disease term including the indexed term and corresponding children terms.
|
|
|
